Live Geos: https://partners.subjectwell.com/publishers/geos_report/c86cf77d-2eb5-4601-93a4-9260a1deeda1 COPY AND CREATIVE MUST BE USED FROM CREATIVE FOLDER. NO OTHER COPY OR CREATIVE WILL BE ALLOWED AT THIS TIME. EMAIL KAYLA.OSWALD@CLARINESS FOR QUESTIONS Age Range: 18-70 Gender: Any Study Description: The purpose of this clinical study is to see how safe and effective an investigational medication is at helping to treat people living with alcohol-related liver disease. You will be asked to attend 2 screening visits to determine if you are eligible to enroll in the study. If enrolled, you will receive either the medication being tested in this study or a placebo (injection that contains no medication) every 4 weeks for 11 months. Your total participation will last approximately 1 year and 4 months, and you will be asked to attend monthly doctor’s visits. During these visits, you will complete various lab tests, physical exams, liver scans, and questionnaires. Participants who qualify may be reimbursed for any expenses incurred and receive a stipend as compensation for time and inconvenience associated with participating in the study. The doctor’s clinic conducting the study will be able to provide you with more information about the study requirements. Study Description Breakdown: Medical indications: Alcoholic Liver Disease, Fatty Liver Disease Exclusionary indications: Not provided Amount of visits: Monthly visits Length of the study: Approximately 1 year and 4 months Medication type: Subcutaneous Injection Doses: Every 4 weeks for 11 months Compensation: No amount provided Qualification Criteria: - Doctor has told you that your alcohol consumption has damaged your liver - Male patient has at any point in your life regularly drunk more than 14 alcoholic drinks per week / Female patient has regularly drunk more than seven drinks per week - Cannot use anticoagulant medication (blood thinners) - Cannot be on dialysis - Cannot have had a heart attack or stroke in past six months

DYNU IN MEDIA